Michelle McDowell
Family · Anderson, INNPI 1124073242
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 102 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Neurocrine Biosciences, Inc. at 29.9% of the total. 2025 is the largest year on record at $841, more than ten times the $25 reported in 2021.
Across 102 payments — averaging $18.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$566
- Gilead$247
- Otsuka America Pharmaceutical, Inc.$210
- Alkermes, Inc.$181
- AbbVie$151
- Acadia Pharmaceuticals Inc$113
- plus $427 from 11 others
What the payments were for
- Food & beverage$1,895100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 44 | $566 |
| Gilead | 4 | $247 |
| Otsuka America Pharmaceutical, Inc. | 10 | $210 |
| Alkermes, Inc. | 9 | $181 |
| AbbVie | 9 | $151 |
| Acadia Pharmaceuticals Inc | 1 | $113 |
| Exact Sciences | 4 | $75 |
| Lundbeck LLC | 4 | $71 |
| Phathom Pharmaceuticals, Inc. | 5 | $49 |
| Boston Scientific | 1 | $45 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $44 |
| Pfizer | 2 | $34 |
| Johnson & Johnson | 2 | $32 |
| Astellas Pharma US Inc | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $18 |
| Genentech USA, Inc. | 2 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Epclusa$105
How this compares
$1,895 in reported general payments places this provider in the 75th percentile of 4,392 family providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 25 | $28,216 |
| JanuviaSitagliptin Phosphate | 11 | $18,170 |
| TrulicityDulaglutide | 13 | $12,771 |
| OzempicSemaglutide | 11 | $10,739 |
| Pregabalin | 14 | $1,263 |
| Gabapentin | 55 | $799 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 30 | $771 |
| Hydroxyzine Hcl | 19 | $629 |
| Omeprazole | 41 | $567 |
| Atorvastatin Calcium | 101 | $462 |
| Levothyroxine Sodium | 34 | $317 |
| Losartan Potassium | 28 | $250 |
| Montelukast Sodium | 21 | $217 |
| Duloxetine Hcl | 13 | $198 |
| Oxybutynin Chloride ErOxybutynin Chloride | 11 | $176 |
Paid to pharmacies, not to this prescriber.
Other family in Anderson
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
- Beverly MaugerFt Wayne$94K
- Nancy ArndtPortage$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.